featured
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-Based Chemotherapy in Muscle-Invasive Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-Based Chemotherapy in Muscle-Invasive Bladder Cancer
Eur Urol 2015 Aug 12;[EPub Ahead of Print], ER Plimack, RL Dunbrack, TA Brennan, MD Andrake, Y Zhou, IG Serebriiskii, M Slifker, K Alpaugh, E Dulaimi, N Palma, J Hoffman-Censits, M Bilusic, YN Wong, A Kutikov, R Viterbo, RE Greenberg, DY Chen, CD Lallas, EJ Trabulsi, R Yelensky, DJ McConkey, VA Miller, EA Golemis, EA RossFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.